FOCUS: Mobile app support for taking oral cancer medicine

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center pilot using the EveryDose mobile application to track prescribed oral anti-cancer treatments and collect patient experiences. Adults with hematologic or solid tumor cancers who are beginning an oral anti-cancer drug for the first time will use the app and provide feedback during the treatment period. Study staff will review user-reported adherence, usability, and safety-related data to understand how the app fits into routine care. Findings will guide whether the team expands to larger evaluations or other supportive methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Any sex/gender Able to provide written informed consent
* Able to read/understand English or Spanish
* Diagnosis of hematologic or solid tumor cancer diagnosis
* Prescribed an oral anti-cancer drug as monotherapy treatment for the first time by their treating oncologist.
* Internet access on a smartphone, tablet, or computer

Exclusion Criteria:

* Less than 18 years of age
* Unable to provide written informed consent
* Unable to read/understand English or Spanish
* History of dementia or major psychiatric disease that would interfere with study participation
* Prior treatment with an oral anti-cancer treatment
* Participating in another clinical trial during the time of screening.

Where it's running

• University of Miami
  Miami, Florida, United States Recruiting

Study contacts

• Principal investigator: Frank Penedo, PhD — University of Miami
• Study coordinator: Jessica MacIntyre, DNP
• Email: jmacintyre@med.miami.edu
• Phone: 305-243-4570

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Neural links for real-world emotions in mood and anxiety

  Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.

  Recruiting University of Miami · Coral Gables, Florida · NCT07891624

• Lixumistat window of opportunity in newly diagnosed glioblastoma

  This study tests whether Lixumistat can benefit adults with newly diagnosed glioblastoma who are planned for surgical tumor removal.

  Recruiting Early Phase 1 University of Miami · Miami, Florida · NCT07884344

• Velocity-Loss Resistance Training in Parkinson's Disease

  This trial tests whether two velocity-loss resistance training thresholds (10% vs 30%) improve muscle strength, power, and daily function in older adults with Parkinson's disease.

  Recruiting University of Miami · Coral Gables, Florida · NCT07840508

• Noninvasive ear stimulation for HIV-related nerve pain

  This study tests a non-invasive ear stimulation device to see if it can help nerve pain in people with HIV who have HIV-associated peripheral neuropathy.

  Recruiting University of Miami · Miami, Florida · NCT07822932

• Brain-avoiding proton craniospinal irradiation for leptomeningeal metastases

  This study tests BRAVO pCSI, a proton therapy approach that avoids certain brain regions, to see if it helps adults with leptomeningeal metastases from solid tumors.

  Recruiting University of Miami · Miami, Florida · NCT07789912

• Active vs Passive Sitting: Testing Cognition, Muscle Use, and Calorie Burn

  Researchers will test how different seated conditions affect thinking speed, muscle use, seated pressure, and calories burned in adults.

  Recruiting University of Miami · Coral Gables, Florida · NCT07699848

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.